– Visionary Breakthrough In Eye Care With NanoSLT –

In the world of cutting-edge eye care, Dr. Cyres Mehta reigns as a beacon of excellence, bringing global recognition, community pride and life-changing breakthroughs in the realm of expert eye-care. Hailed as the ‘International Hero of Indian Ophthalmology’, Dr. Mehta is globally recognised for his pioneering work and relentless pursuit of innovation in this field. At the heart of his achievements lies a deep commitment to saving and improving vision, especially in combating one of the most insidious causes of blindness – Glaucoma.

Often dubbed the ‘silent thief of sight’, Glaucoma is fast becoming a public health crisis in India, affecting a large part of the population. This progressive eye disease raises pressure within the eye, gradually damaging the optic nerve and leading to irreversible blindness if left untreated. Traditionally, treatment involved lifelong dependence on medicated eye drops – often accompanied by frustrating side-effects, or invasive surgery, which, while effective in some cases, carries risks like bleeding and dangerously low eye pressure that could compromise vision.

In keeping with his legacy of always being ahead of the curve, Dr. Cyres Mehta is now transforming the way glaucoma is treated in India with the introduction of NanoSLT – a groundbreaking, non-invasive laser treatment that is swiftly becoming the gold standard for glaucoma-care, worldwide.

“This new device, approved by the US FDA, is fast replacing eye-drops as the first line of treatment for glaucoma,” explains Dr. Mehta. “It’s a painless, clinic-based procedure that takes just 2-3 minutes per eye and can be safely repeated without side effects. The results have been phenomenal, offering patients freedom from drops and the risk factors of surgery.” The NanoSLT laser represents a leap forward in ophthalmology – safe, efficient and remarkably effective. It is a testament to Dr. Mehta’s unwavering dedication to bring the very best of global technology home to his patients in India.

What makes this advancement even more impressive is that NanoSLT is part of a seamless, comprehensive treatment protocol offered at Dr. Cyres Mehta’s International Eye Centre, located in Colaba, South Mumbai. Here, patients diagnosed with both Glaucoma and Cataract can benefit from an extraordinary combination: first the NanoSLT laser for glaucoma, followed by state-of-the-art Robotic Laser Cataract Surgery. This rare fusion of technologies places the Centre among the few in the world to offer such advanced and holistic care.

Dr. Cyres Mehta’s contributions to ophthalmology extend well beyond Glaucoma. In 2015, he introduced Maharashtra’s first FLACS (Femto Laser-Assisted Cataract Surgery) using the advanced CATALYS system – redefining precision and safety in cataract procedures. His internationally reputed centre also offers Trifocal and Extended Depth of Focus Lens Implantation, Canaloplasty for glaucoma and SMILE Robotic Refractive Surgery, drawing patients from over 20 countries. A global torchbearer of Ophthalmic excellence, his pioneering work with NanoSLT represents a new dawn in glaucoma care.

The recipient of over 60 prestigious national and global awards – including multiple honours as ‘India’s Leading Eye Surgeon’, Dr. Mehta has brought immense pride to the nation and the Parsi community, as he continues to elevate global standards in eye care. With a legacy rooted in innovation, precision and heartfelt care, Dr. Cyres Mehta stands among the world’s most distinguished names in eye care, transforming lives one breakthrough at a time.

With the future of cutting-edge glaucoma treatment delivered with precision now within reach, this is the perfect time to safeguard your vision, under the expert care of global luminary Dr. Cyres Mehta, whose achievements reflect the pride and promise of our community.